Kura Oncology Provides Update on Phase 1b Study of KO-539 in Acute Myeloid Leukemia
Go back to Kura Oncology Provides Update on Phase 1b Study of KO-539 in Acute Myeloid Leukemia| (NASDAQ: KURA) | Delayed: 11.72 +0.52 (4.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.20 | 52 Week High | $8.90 | |||
| Open | $11.39 | 52 Week Low | $2.50 | |||
| Day High | $12.20 | P/E | N/A | |||
| Day Low | $11.35 | EPS | $0.00 | |||
| Volume | 1,852,047 | |||||
